glp-1 for metabolic syndrome Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism GLP-1 for Prevention: Using Drugs

If we dont deal with the problem, then were just amplifying the yo-yo thats been here for many years losing weight, regaining it, says Wyatt, coauthor of Losing the Weight Loss Meds: A 10-Week Playbook for Stopping GLP-1 Medications Without Regaining the Weight

Gerstein HC, Colhoun HM, Dagenais GR et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

The theoretical risk requires a lifetime contraindication in patients with a personal or family history of medullary thyroid cancer (MTC) or menin-2 (Mary and Curtis 2010

There are two key hormones involved: Glucose Dependant Insulinotropic Polypeptide or GIP and Glucagon like Peptide #1 or GLP-1